HF
ACET icon

HRT Financial’s Adicet Bio ACET Stock Holding History

HRT Financial’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,164
Closed -$15K – 3101
2025
Q3 		$15K Buy
+1,164
New +$13.7K ﹤0.01% 2726
2024
Q3 		– Sell
-3,995
Closed -$77K – 2327
2024
Q2 		$77K Buy
+3,995
New +$107K ﹤0.01% 1790
2022
Q1 		– Sell
-679
Closed -$190K – 3003
2021
Q4 		$190K Buy
+679
New +$117K ﹤0.01% 2554

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

HRT Financial's ACET Position: Q4 2025 in Review

HRT Financial sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 1,164 shares — an estimated $15K sold.

HRT Financial first reported a position in ACET in Q4 2021 and held it in 3 quarters. The position peaked at $190K in Q4 2021. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • HRT Financial reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 1,164 Adicet Bio shares in Q4 2025, an estimated $15K.
  • HRT Financial first reported a position in Adicet Bio in Q4 2021 and held it in 3 quarters.
  • HRT Financial's Adicet Bio position peaked at $190K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.